Predictions
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.30
02.06.21
02.06.21
-
02.06.22
02.06.22
9.09%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
M1 Kliniken AG
Start price
Target price
Perf. (%)
€10.35
31.05.21
31.05.21
-
31.05.24
31.05.24
40.10%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Haemato AG
Start price
Target price
Perf. (%)
€29.20
31.05.21
31.05.21
-
31.05.24
31.05.24
-36.99%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€75.60
26.05.21
26.05.21
€82.00
26.05.22
26.05.22
-36.11%
27.05.22
27.05.22
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€74.55
07.05.21
07.05.21
€60.00
07.05.22
07.05.22
-37.42%
08.05.22
08.05.22
Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€40.55
04.05.21
04.05.21
€55.00
04.05.22
04.05.22
-11.84%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€81.20
03.05.21
03.05.21
€75.00
03.05.22
03.05.22
-41.82%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Haemato AG
Start price
Target price
Perf. (%)
€28.90
02.05.21
02.05.21
€35.00
02.05.22
02.05.22
-4.50%
15.05.21
15.05.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.70
02.05.21
02.05.21
-
02.05.22
02.05.22
1.08%
16.05.21
16.05.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Formycon AG
Start price
Target price
Perf. (%)
€66.90
18.04.21
18.04.21
-
18.04.22
18.04.22
-16.59%
21.12.21
21.12.21
Could be worthwhile Investment >10% per year
Sartorius AG VZO
Start price
Target price
Perf. (%)
€468.70
16.04.21
16.04.21
€440.00
16.04.22
16.04.22
-18.50%
17.04.22
17.04.22
Probably not worthwhile Investment
Very low/no dividend yield expected
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€73.50
15.04.21
15.04.21
€88.00
15.04.22
15.04.22
10.48%
03.05.21
03.05.21
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€2.47
06.04.21
06.04.21
-
06.04.24
06.04.24
-84.62%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Merck KGaA
Start price
Target price
Perf. (%)
€144.40
25.03.21
25.03.21
€130.00
25.03.22
25.03.22
56.79%
14.12.21
14.12.21
Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-21.91%
09.03.22
09.03.22
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-26.29%
09.03.22
09.03.22
Bayer AG ADR
Start price
Target price
Perf. (%)
€13.10
08.03.21
08.03.21
€14.00
3.05%
10.03.21
10.03.21
EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
MorphoSys AG
Start price
Target price
Perf. (%)
€82.98
08.03.21
08.03.21
-
08.03.22
08.03.22
-72.98%
09.03.22
09.03.22
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
Stratec SE
Start price
Target price
Perf. (%)
€116.60
03.03.21
03.03.21
€165.00
03.10.22
03.10.22
3.43%
06.04.22
06.04.22
Could be worthwhile Investment >10% per year